Julia G. Butchko, Chief Development & Technology Officer at Immunovant, Inc. (IMVT), sold 110,636 shares at $7.25 ($802K) on 2022-01-07, disclosed to the SEC on 2022-01-11.
Open-market sale of $802k IMVT by Chief Development & Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.25 | 55,318 | $401K | 50.0% |
| 2 | $7.25 | 55,318 | $401K | 50.0% |
| Total | $7.25 avg | 110,636 | $802K | 100% |
| Filing → |
| IMVT | SELL | 2024-07-10 | $43K | — | Filing → |
| IMVT | SELL | 2024-05-24 | $193K | — | Filing → |
| IMVT | SELL | 2024-04-19 | $362K | — | Filing → |